• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病合并大肠息肉患者血清半乳糖凝集素-3水平的横断面研究

Cross-Sectional Study of Serum Galectin-3 Levels in Patients with Type 2 Diabetes and Colorectal Polyps.

作者信息

Storman Monika, Przybyłkowski Adam, Czupryniak Leszek

机构信息

Department of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Banacha 1a, 02-304 Warsaw, Poland.

Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-304 Warsaw, Poland.

出版信息

Int J Mol Sci. 2025 Aug 8;26(16):7662. doi: 10.3390/ijms26167662.

DOI:10.3390/ijms26167662
PMID:40868983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386645/
Abstract

Galectin-3 (Gal-3) secreted by activated macrophages is involved in inflammation, fibrosis, and tumorigenesis. It is considered a potential biomarker and therapeutic target. This study assessed the association between serum Gal-3, type 2 diabetes (T2D), and colorectal polyps (CRPs). In this cross-sectional study, 80 non-cancer patients undergoing colonoscopy were divided into four subgroups based on T2D and CRP status. Serum Gal-3 and metabolic parameters were measured. All patients' mean serum Gal-3 level was 13.63 ng/mL. Gal-3 levels were significantly higher in T2D+ than in the T2D- group (14.93 ng/mL, = 0.02). Gal-3 concentration correlated significantly with age (rho = 0.281; = 0.012), gender (rho = 0.220; = 0.049), serum peptide C levels (rho = 0.957; = 0.006), and serum IGF-1 levels (rho = -0.417; < 0.001) in all patients, and for patients T2D-, it also correlated significantly with fasting plasma glucose levels (rho = -0.406; = 0.009). A logistic regression analysis of the risk of polyps was conducted (CRP+ vs. CRP-) considering factors such as gender, age, body weight, waist circumference, T2D, HOMA-IR, insulin, API, IGF-1, total cholesterol, and Gal-3. Gal-3 serum was shown to be a strong independent predictor of CRPs regardless of the presence of T2D+ ( = 0.031). Gal-3 may correlate with the development of CRPs and might be a candidate biomarker of CRPs/cancer development.

摘要

活化巨噬细胞分泌的半乳糖凝集素-3(Gal-3)参与炎症、纤维化和肿瘤发生过程。它被认为是一种潜在的生物标志物和治疗靶点。本研究评估了血清Gal-3、2型糖尿病(T2D)和结直肠息肉(CRP)之间的关联。在这项横断面研究中,80名接受结肠镜检查的非癌症患者根据T2D和CRP状态分为四个亚组。测量了血清Gal-3和代谢参数。所有患者的血清Gal-3平均水平为13.63 ng/mL。T2D+组的Gal-3水平显著高于T2D-组(14.93 ng/mL,P = 0.02)。在所有患者中,Gal-3浓度与年龄(rho = 0.281;P = 0.012)、性别(rho = 0.220;P = 0.049)、血清肽C水平(rho = 0.957;P = 0.006)和血清IGF-1水平(rho = -0.417;P < 0.001)显著相关,对于T2D-患者,它还与空腹血糖水平显著相关(rho = -0.406;P = 0.009)。考虑性别、年龄、体重、腰围、T2D、HOMA-IR、胰岛素、API、IGF-1、总胆固醇和Gal-3等因素,对息肉风险进行了逻辑回归分析。无论是否存在T2D+,血清Gal-3均被证明是CRP的强有力独立预测因子(P = 0.031)。Gal-3可能与CRP的发生相关,可能是CRP/癌症发生的候选生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12386645/882bda55c8c6/ijms-26-07662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12386645/bf9804d83394/ijms-26-07662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12386645/882bda55c8c6/ijms-26-07662-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12386645/bf9804d83394/ijms-26-07662-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c81/12386645/882bda55c8c6/ijms-26-07662-g002.jpg

相似文献

1
Cross-Sectional Study of Serum Galectin-3 Levels in Patients with Type 2 Diabetes and Colorectal Polyps.2型糖尿病合并大肠息肉患者血清半乳糖凝集素-3水平的横断面研究
Int J Mol Sci. 2025 Aug 8;26(16):7662. doi: 10.3390/ijms26167662.
2
Association Between Serum Vitamin D and Albuminuria in Type 2 Diabetes Independent of Inflammatory Markers and Renal Function.2型糖尿病患者血清维生素D与白蛋白尿之间的关联:独立于炎症标志物和肾功能
Endocrinol Diabetes Metab. 2025 Sep;8(5):e70093. doi: 10.1002/edm2.70093.
3
Galectin-3 Reflects Systemic Atherosclerosis in Patients with Coronary Artery Disease.半乳糖凝集素-3反映冠心病患者的全身性动脉粥样硬化。
Medicina (Kaunas). 2025 Jul 30;61(8):1388. doi: 10.3390/medicina61081388.
4
Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.替尔泊肽10毫克和15毫克与司美格鲁肽2.4毫克治疗2型糖尿病患者肥胖和超重的间接比较疗效与安全性
Diabetes Obes Metab. 2025 Jun 19. doi: 10.1111/dom.16508.
5
Atrial dysfunction: a contrast-free marker for HFpEF in obese diabetics-insights from comprehensive CMR and serum biomarker analyses.心房功能障碍:肥胖糖尿病患者射血分数保留的心力衰竭的无对比剂标志物——来自全面心脏磁共振成像和血清生物标志物分析的见解
Cardiovasc Diabetol. 2025 Jun 18;24(1):258. doi: 10.1186/s12933-025-02808-3.
6
Association between serum uric acid levels and galectin-3 in patients with uncomplicated type 2 diabetes.单纯2型糖尿病患者血清尿酸水平与半乳糖凝集素-3之间的关联
Intern Med J. 2025 Jul;55(7):1169-1173. doi: 10.1111/imj.70070. Epub 2025 Apr 11.
7
Serum sICAM-1 and Galectin-3 Levels in Diabetic Patients with COVID-19.2019冠状病毒病糖尿病患者的血清可溶性细胞间黏附分子-1和半乳糖凝集素-3水平
Viruses. 2025 Jul 17;17(7):1005. doi: 10.3390/v17071005.
8
Clinical utility of GAL-8, ITGΒ-1, and HIF-1α as non-invasive diagnostic and prognostic biomarkers for assessing glioma.GAL-8、ITGΒ-1和HIF-1α作为评估神经胶质瘤的非侵入性诊断和预后生物标志物的临床效用。
J Neurooncol. 2025 Jun 13. doi: 10.1007/s11060-025-05110-0.
9
Assessment and prediction of diabetic kidney disease in patients with type 2 diabetes mellitus by using an advanced biomarkers.使用先进生物标志物对2型糖尿病患者的糖尿病肾病进行评估和预测。
Nefrologia (Engl Ed). 2025 Jun-Jul;45(6):101330. doi: 10.1016/j.nefroe.2025.101330.
10
Association of incidence of colorectal polyp with markers of insulin resistance and other related factors: a cross-sectional study.结肠息肉发病率与胰岛素抵抗标志物及其他相关因素的关联:一项横断面研究
Sci Rep. 2025 Jul 4;15(1):23969. doi: 10.1038/s41598-025-08505-1.

本文引用的文献

1
Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis.循环半乳糖凝集素-3 水平与糖尿病肾病:系统评价和荟萃分析。
BMC Nephrol. 2023 Jun 8;24(1):163. doi: 10.1186/s12882-023-03226-x.
2
Emerging roles of Galectin-3 in diabetes and diabetes complications: A snapshot.Galectin-3 在糖尿病及其并发症中的新兴作用:快照。
Rev Endocr Metab Disord. 2022 Jun;23(3):569-577. doi: 10.1007/s11154-021-09704-7. Epub 2022 Jan 27.
3
Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents.
糖尿病与结直肠癌风险:分子机制的新视角及新型抗糖尿病药物的潜在作用。
Int J Mol Sci. 2021 Nov 17;22(22):12409. doi: 10.3390/ijms222212409.
4
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.结直肠癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2021 May 18;325(19):1978-1998. doi: 10.1001/jama.2021.4417.
5
Association of circulating galectin-3 with gestational diabetes mellitus, progesterone, and insulin resistance.循环半乳糖凝集素-3 与妊娠期糖尿病、孕酮和胰岛素抵抗的关系。
J Diabetes. 2021 Jan;13(1):54-62. doi: 10.1111/1753-0407.13088. Epub 2020 Sep 2.
6
Galectin-3 may serve as a marker for poor prognosis in colorectal cancer: A meta-analysis.半乳糖凝集素-3 可作为结直肠癌不良预后的标志物:一项荟萃分析。
Pathol Res Pract. 2019 Oct;215(10):152612. doi: 10.1016/j.prp.2019.152612. Epub 2019 Aug 20.
7
Assessment of serum galectin-3, methylated arginine and Hs-CRP levels in type 2 diabetes and prediabetes.评估 2 型糖尿病和糖尿病前期患者血清半乳糖凝集素-3、甲基精氨酸和 Hs-CRP 水平。
Life Sci. 2019 Aug 15;231:116577. doi: 10.1016/j.lfs.2019.116577. Epub 2019 Jun 15.
8
Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies.半乳糖凝集素-3表达在实体瘤患者中的预后作用:36项符合条件研究的荟萃分析
Cancer Cell Int. 2018 Nov 3;18:172. doi: 10.1186/s12935-018-0668-y. eCollection 2018.
9
Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.粪便半乳糖凝集素-3:结直肠癌严重程度和进展的新有前途的生物标志物。
Mediators Inflamm. 2018 Apr 4;2018:8031328. doi: 10.1155/2018/8031328. eCollection 2018.
10
Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis.半乳糖凝集素-3与癌胚抗原之间的协同相互作用促进结直肠癌转移。
Oncotarget. 2017 Jun 27;8(37):61935-61943. doi: 10.18632/oncotarget.18721. eCollection 2017 Sep 22.